MyFinsight
Home
Blog
About
Net increase
(decrease) in cash and cash...
-$80,451K
Issuance of common stock
in connection with...
$109,243K
Proceeds from former
parent company with...
$100,000K
Proceeds from public
offerings
$75,200K
Proceeds from the
issuance of common stock...
$2,122K
Stock-based compensation
$8,319K
Accounts payable and
other liabilities
$5,236K
Accretion/amortization of investments,
net
-$146K
Depreciation and
amortization
$105K
Amortization of right-of-use
assets - operating
$102K
Net cash provided by
(used in) financing...
-$48,508K
Net cash used in
operating activities
-$31,918K
Net cash provided by
investing activities
-$25K
Canceled cashflow
$286,565K
Canceled cashflow
$13,908K
Net parent
investment
$335,047K
Net loss
-$33,374K
Purchases of property and
equipment
$25K
Payments for offering
costs
$26K
Prepaid expenses and
other assets
$12,359K
Operating lease
liabilities
-$93K
Back
Back
Cash Flow
First Tracks Biotherapeutics, Inc. (TRAX)
First Tracks Biotherapeutics, Inc. (TRAX)
source: myfinsight.com